Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Fuji
Mallinckrodt
QuintilesIMS
US Army
Federal Trade Commission
Citi
Harvard Business School
Baxter

Generated: April 25, 2018

DrugPatentWatch Database Preview

Details for Patent: 7,975,690

« Back to Dashboard

Summary for Patent: 7,975,690
Title:Nasal devices
Abstract: The present invention relates to a nasal delivery device for and a method of delivering a substance, in particular one of a liquid, as a suspension or solution, or a powder containing a medicament, especially systemic or topical pharmaceuticals, or a vaccine to the nasal airway of a subject.
Inventor(s): Djupesland; Per Gisle (Olso, NO)
Assignee: OptiNose AS (Oslo, NO)
Application Number:10/480,582
Patent Claim Types:
see list of patent claims
Use; Delivery; Device; Formulation;

Drugs Protected by US Patent 7,975,690

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Avanir Pharms ONZETRA XSAIL sumatriptan succinate POWDER;INHALATION 206099-001 Jan 27, 2016 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y METHOD OF DRUG DELIVERY VIA THE NASAL CAVITY ➤ Try a Free Trial
Optinose Us Inc XHANCE fluticasone propionate SPRAY, METERED;NASAL 209022-001 Sep 18, 2017 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial METHOD OF DELIVERING FLUTICASONE PROPIONATE TO A NASAL AIRWAY ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 7,975,690

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom0114272.8Jun 12, 2001
PCT Information
PCT FiledJune 12, 2002PCT Application Number:PCT/IB02/03034
PCT Publication Date:January 03, 2003PCT Publication Number: WO03/000310

Non-Orange Book US Patents Family Members for Patent 7,975,690

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,555,877 Nasal delivery device ➤ Try a Free Trial
8,511,303 Nasal delivery devices ➤ Try a Free Trial
7,543,581 Nasal devices ➤ Try a Free Trial
9,468,727 Nasal delivery ➤ Try a Free Trial
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 7,975,690

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 285810 ➤ Try a Free Trial
Austria 422923 ➤ Try a Free Trial
Austria 427130 ➤ Try a Free Trial
Austria 487506 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Johnson and Johnson
Farmers Insurance
Cantor Fitzgerald
Federal Trade Commission
Chinese Patent Office
Colorcon
Queensland Health
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.